NCT02029833

Brief Summary

The objectives of the study are to examine the health benefits of dietary canola oils on body composition, specifically on android fat, and weight management. COMIT II will also include analysis of FAEs to elucidate the mechanisms by which canola oil may be modifying body composition. Measurement of endothelial function, inflammatory, adiposity, and insulin sensitivity biomarkers will be done to determine the positive health impact of the changes in body composition achieved through canola oil consumption.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
125

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2013

Longer than P75 for not_applicable

Geographic Reach
2 countries

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2013

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

December 9, 2013

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 8, 2014

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
Last Updated

March 17, 2023

Status Verified

April 1, 2021

Enrollment Period

3.7 years

First QC Date

December 9, 2013

Last Update Submit

March 15, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Abdominal imaging of visceral and subcutaneous abdominal fat

    Using a Dual Energy X-Ray Absorptiometry machine to analyze body composition, including measuring visceral adiposity. Units (fat mass) measured are cm3 and lbs.

    6 weeks

Secondary Outcomes (15)

  • Analysis of fatty acid ethanolamides and precursors

    6 weeks

  • Total lipid profiles including total cholesterol, high-density lipoprotein-cholesterol, low-density lipoprotein-cholesterol, triglyceride, and free fatty acid levels

    6 weeks

  • Plasma insulin level

    6 weeks

  • Plasma glucose level

    6 weeks

  • Plasma C-reactive protein level

    6 weeks

  • +10 more secondary outcomes

Study Arms (3)

Regular Canola Oil

EXPERIMENTAL

60% oleic acid

Other: Regular Canola Oil

High Oleic Canola Oil

EXPERIMENTAL

70% oleic acid

Other: High Oleic Canola Oil

Western Type Diet - Common Dietary Oils

ACTIVE COMPARATOR

Ghee, Safflower oil, Coconut oil, \& flax oil

Other: Western Type Diet - Common Dietary Oils

Interventions

Regular Canola Oil
High Oleic Canola Oil
Western Type Diet - Common Dietary Oils

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Waist circumference ≥94 cm for men and ≥80 cm for women
  • Fasting blood glucose of ≥ 5.6 mmol/L
  • Triglycerides (TG) ≥1.7 mmol/L
  • HDL cholesterol (HDL) \<1 mmol/L (males) or \<1.3 mmol/L (females)
  • Blood pressure ≥130 mmHg (systolic) and/or ≥85 mmHg (diastolic).

You may not qualify if:

  • Kidney, or liver disease, or unstable thyroid disease
  • Diabetes mellitus
  • Smokers
  • Those consuming \>1 alcoholic beverage a day for women and \>2 for men.
  • Any participant taking medication known to affect lipid metabolism or endothelial function

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

The Pennsylvania State University

University Park, Pennsylvania, 16802, United States

Location

St Boniface Hospital Research

Winnipeg, Manitoba, R2H 2A6, Canada

Location

Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba

Winnipeg, Manitoba, R3T 6C5, Canada

Location

Institute of Nutrition and Functional Foods, Laval University

Québec, Quebec, G1V 0A6, Canada

Location

Related Publications (2)

  • Hammad SS, Eck P, Sihag J, Chen X, Connelly PW, Lamarche B, Couture P, Guay V, Maltais-Giguere J, West SG, Kris-Etherton PM, Bowen KJ, Jenkins DJA, Taylor CG, Perera D, Wilson A, Castillo S, Zahradka P, Jones PJH. Common Variants in Lipid Metabolism-Related Genes Associate with Fat Mass Changes in Response to Dietary Monounsaturated Fatty Acids in Adults with Abdominal Obesity. J Nutr. 2019 Oct 1;149(10):1749-1756. doi: 10.1093/jn/nxz136.

  • Bowen KJ, Kris-Etherton PM, West SG, Fleming JA, Connelly PW, Lamarche B, Couture P, Jenkins DJA, Taylor CG, Zahradka P, Hammad SS, Sihag J, Chen X, Guay V, Maltais-Giguere J, Perera D, Wilson A, Juan SCS, Rempel J, Jones PJH. Diets Enriched with Conventional or High-Oleic Acid Canola Oils Lower Atherogenic Lipids and Lipoproteins Compared to a Diet with a Western Fatty Acid Profile in Adults with Central Adiposity. J Nutr. 2019 Mar 1;149(3):471-478. doi: 10.1093/jn/nxy307.

MeSH Terms

Conditions

Cardiovascular DiseasesDiabetes MellitusMetabolic Syndrome

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesInsulin ResistanceHyperinsulinism

Study Officials

  • Peter Jones, PhD

    University of Manitoba

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 9, 2013

First Posted

January 8, 2014

Study Start

March 1, 2013

Primary Completion

November 1, 2016

Study Completion

November 1, 2016

Last Updated

March 17, 2023

Record last verified: 2021-04

Locations